Intended for healthcare professionals

Rapid response to:

Analysis

Challenges of independent assessment of potential harms of HPV vaccines

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3694 (Published 24 September 2018) Cite this as: BMJ 2018;362:k3694

Rapid Response:

Re: Challenges of independent assessment of potential harms of HPV vaccines

In the light of this information [1] what are the ethical grounds for the continued prescription of these products which seem to be neither properly tested or monitored? How can we look to some long term nebulous benefit when public agencies are apparently so negligent of safety? And what do we do about those agencies?

I have also been reading with dismay the shortly to be published 'The HPV Vaccine On Trial: Seeking Justice for a Generation Betrayed' [2] which parallels and augments much of what has been said here.

[1] Lars Jørgensen, Peter Doshi, Peter Gøtzsche, Tom Jefferson, 'Challenges of independent assessment of potential harms of HPV vaccines', BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3694 (Published 24 September 2018)

[2] Mary Holland, Kim Mack Rosenberg and Eileen Iorio, 'The HPV Vaccine On Trial: Seeking Justice for a Generation Betrayed' with an introduction by Luc Montagnier, Skyhorse, 2 October 2018

Competing interests: No competing interests

25 September 2018
John Stone
UK Editor
AgeofAutism.com
London N22